BioSIM 抗人 PD-L1/CD274 抗体 (舒格利单

BioSIM 抗人 PD-L1/CD274 抗体 (舒格利单抗)，生物类似药

产品概述

BioSIM anti-Human PD-L1/CD274 Antibody (Sugemalimab Biosimilar) 是一款高质量的科研级抗体，由InvivoCrown公司生产，货号SIM0613-5mg。该抗体作为舒格利单抗的生物类似药，专为科研用途设计，可特异性识别人源PD-L1/CD274蛋白，广泛应用于肿瘤免疫学及相关癌症研究。

技术特点

• 高特异性：针对人源PD-L1/CD274蛋白的特异性结合
• 无动物成分：在无动物成分的设施中生产，降低实验干扰因素
• 高纯度：采用多步骤纯化工艺，包括Protein A或G色谱技术
• 无蛋白培养基：使用体外无蛋白细胞培养技术生产
• 人源来源：来源于人类宿主，提高与人源样本的相容性

研究领域

该抗体主要应用于以下癌症研究领域：

• 非小细胞肺癌（NSCLC）的免疫机制研究
• 食道癌的免疫治疗靶点探索
• 胃癌的免疫微环境分析

应用类型

BioSIM 抗人 PD-L1/CD274 抗体适用于多种实验方法：

• ELISA：可用于定量检测样本中PD-L1/CD274的表达水平
• FACS：流式细胞术分析，适用于细胞表面PD-L1/CD274的表达研究
• Functional assay：功能实验，评估PD-L1/CD274在免疫调节中的作用
• Research in vivo：体内研究，探索肿瘤微环境中PD-L1/CD274的生物学功能

产品规格

使用建议

本产品为科研用途，请严格按照产品说明书进行操作。免疫原信息请参考产品说明书。建议在使用前进行适当的优化实验，确定最佳工作浓度和实验条件。如需进一步技术支持，请联系InvivoCrown公司技术团队。

注意：以上信息可能随着产品优化升级等因素产生变动，具体信息请咨询亚科因公司。

BioSIM Anti-Human PD-L1/CD274 Antibody (Sugemalimab Biosimilar)

Product Overview

BioSIM anti-Human PD-L1/CD274 Antibody (Sugemalimab Biosimilar) is a high-quality research-grade antibody produced by InvivoCrown, with the product code SIM0613-5mg. As a biosimilar of Sugemalimab, it is designed specifically for research purposes and can specifically recognize human PD-L1/CD274 protein, and is widely used in tumor immunology and related cancer research.

Technical Features

• High Specificity: Specific binding to human PD-L1/CD274 protein
• Animal Component-Free: Produced in an animal-component-free facility, reducing experimental interference factors
• High Purity: Adopting multi-step purification processes, including Protein A or G chromatography techniques
• Protein-Free Medium: Produced using in vitro protein-free cell culture technology
• Human Origin: Derived from a human host, improving compatibility with human samples

Research Fields

This antibody is mainly applied in the following cancer research fields:

• Immune mechanism research of non-small cell lung cancer (NSCLC)
• Exploration of immunotherapy targets in esophageal cancer
• Analysis of the immune microenvironment in gastric cancer

Application Types

BioSIM anti-Human PD-L1/CD274 Antibody is suitable for various experimental methods:

• ELISA: Can be used for quantitative detection of the expression level of PD-L1/CD274 in samples
• FACS: Flow cytometry analysis, suitable for the study of the expression of PD-L1/CD274 on the cell surface
• Functional assay: Functional experiment to evaluate the role of PD-L1/CD274 in immune regulation
• Research in vivo: In vivo research to explore the biological function of PD-L1/CD274 in the tumor microenvironment

Product Specifications

Usage Suggestions

This product is for research purposes only. Please operate strictly according to the product manual. Refer to the product manual for immunogen information. It is recommended to conduct appropriate optimization experiments before use to determine the optimal working concentration and experimental conditions. For further technical support, please contact the technical team of InvivoCrown.

Note: The above information may change due to product optimization and upgrading. For specific information, please consult Yakeyin Company.